Challenges of alloimmunization in patients with haemoglobinopathies
- 4 October 2012
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 159 (4) , 394-404
Abstract
Summary: Red blood cell (RBC) transfusions can be life‐sustaining in chronic inherited anaemias, such as thalassaemia, and the indications for blood transfusions in patients with sickle cell disease continue to expand. Complications of transfusions, such as allosensitization, can create significant medical challenges in the management of patients with haemoglobinopathies. This review summarizes key findings from the medical literature related to alloimmunization in haemoglobinopathies and examines potential measures to mitigate these risks. Areas where future studies are needed are also addressed.Keywords
This publication has 100 references indexed in Scilit:
- Hemoglobin-driven pathophysiology is an in vivo consequence of the red blood cell storage lesion that can be attenuated in guinea pigs by haptoglobin therapyJournal of Clinical Investigation, 2012
- Immune regulation in chronically transfused allo‐antibody responder and nonresponder patients with sickle cell disease and β‐thalassemia majorAmerican Journal of Hematology, 2011
- Alloimmunization to transfused HOD red blood cells is not increased in mice with sickle cell diseaseTransfusion, 2011
- Storage lesion: role of red blood cell breakdownTransfusion, 2011
- Delayed hemolytic transfusion reaction in children with sickle cell diseaseHaematologica, 2011
- Duration of red blood cell storage and survival of transfused patients (CME)Transfusion, 2010
- Transfusion of red blood cells after prolonged storage produces harmful effects that are mediated by iron and inflammationBlood, 2010
- IMMUNOHEMATOLOGY: Storage of murine red blood cells enhances alloantibody responses to an erythroid‐specific model antigenTransfusion, 2010
- Delayed Hemolytic Transfusion Reaction in Sickle Cell DiseaseThe American Journal of the Medical Sciences, 2010
- Complications and treatment of patients with -thalassemia in France: results of the National RegistryHaematologica, 2009